NRX-101 for Bipolar Depression With Subacute Suicidal Ideation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan C Javitt, MD, MPH
NRx Pharmaceuticals
Study Chair - Martin Brecher, MD
NRx Pharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Science 37
Culver City, California, United States
- San Marcus Research Clinic, Inc.
Miami Lakes, Florida, United States
- Acmr
Atlanta, Georgia, United States
- Iresearch Atlanta, Llc
Decatur, Georgia, United States
- Iresearch Savannah
Savannah, Georgia, United States
- Cbh Health
Gaithersburg, Maryland, United States
- Omaha Insomnia and Psychiatric Services
Omaha, Nebraska, United States
- Dent Neurologic Institute
Amherst, New York, United States
- Peace Health Medical Group
Eugene, Oregon, United States
- Roots Behavioral Health
Austin, Texas, United States
- University of Texas Health Austin
Austin, Texas, United States
- Jps Health
Fort Worth, Texas, United States
- Houston Mind and Brain
Houston, Texas, United States
- Health Texas
Richmond, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 May 2022
- Primary completion
- 28 Feb 2024
- Completion
- 30 Mar 2024
- Last update posted
- 8 May 2024
- Registered enrollment
- 74
- Registry id
- NCT03395392
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.